Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value GBP0.05 per share
-
Shares outstanding
-
84.8M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
62.6M
-
Shares change
-
+2.37M
-
Total reported value, excl. options
-
$1.33B
-
Value change
-
+$49.5M
-
Put/Call ratio
-
0.69
-
Number of buys
-
45
-
Number of sells
-
-42
-
Price
-
$21.14
Significant Holders of Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) as of Q2 2023
120 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q2 2023.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.6M shares
of 84.8M outstanding shares and own 73.76% of the company stock.
Largest 10 shareholders include FMR LLC (7.11M shares), RA CAPITAL MANAGEMENT, L.P. (6.32M shares), NEA Management Company, LLC (5.11M shares), PERCEPTIVE ADVISORS LLC (4.4M shares), WELLINGTON MANAGEMENT GROUP LLP (4.3M shares), Vivo Capital, LLC (4.25M shares), ORBIMED ADVISORS LLC (3.78M shares), Deep Track Capital, LP (3.19M shares), Frazier Life Sciences Management, L.P. (2.94M shares), and Octagon Capital Advisors LP (2.47M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.